GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » LeMaitre Vascular Inc (FRA:LHU) » Definitions » Debt-to-Revenue

LeMaitre Vascular (FRA:LHU) Debt-to-Revenue : 0.09 (As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is LeMaitre Vascular Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

LeMaitre Vascular's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was €2.3 Mil. LeMaitre Vascular's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was €15.0 Mil. LeMaitre Vascular's annualized Revenue for the quarter that ended in Mar. 2024 was €196.8 Mil. LeMaitre Vascular's annualized Debt-to-Revenue for the quarter that ended in Mar. 2024 was 0.09.


LeMaitre Vascular Debt-to-Revenue Historical Data

The historical data trend for LeMaitre Vascular's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LeMaitre Vascular Debt-to-Revenue Chart

LeMaitre Vascular Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.13 0.42 0.10 0.10 0.10

LeMaitre Vascular Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.09 0.08 0.09 0.10 0.09

Competitive Comparison of LeMaitre Vascular's Debt-to-Revenue

For the Medical Instruments & Supplies subindustry, LeMaitre Vascular's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


LeMaitre Vascular's Debt-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, LeMaitre Vascular's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where LeMaitre Vascular's Debt-to-Revenue falls into.



LeMaitre Vascular Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

LeMaitre Vascular's Debt-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(2.266 + 15.244) / 177.425
=0.10

LeMaitre Vascular's annualized Debt-to-Revenue for the quarter that ended in Mar. 2024 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(2.326 + 15.046) / 196.8
=0.09

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Mar. 2024) Revenue data.


LeMaitre Vascular Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of LeMaitre Vascular's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


LeMaitre Vascular (FRA:LHU) Business Description

Traded in Other Exchanges
Address
63 Second Avenue, Burlington, MA, USA, 01803
LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are primarily used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes the largest proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches, and vessel closure systems. LeMaitre generates the majority of its revenue in the United States.

LeMaitre Vascular (FRA:LHU) Headlines

No Headlines